Unknown NA INTERVENTIONAL 3-arm NCT04228315

Biomarkers of P. Vivax Relapse

Identification of Hypnozoite Biomarkers and Relapse Patterns of Plasmodium Vivax

Sponsor: Armed Forces Research Institute of Medical Sciences, Thailand

Conditions CYP2D6 Polymorphism Malaria Relapse Vivax Malaria

Interventions Primaquine

Updated 5 times since 2020 Last updated: Jan 10, 2020 Started: Nov 19, 2019 Primary completion: Jun 30, 2021 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on CYP2D6 Polymorphism and Malaria, this trial is ongoing. The trial is conducted by Armed Forces Research Institute of Medical Sciences, Thailand and has accumulated 5 data snapshots since 2019. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Feb 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2021 — Jul 2024 [monthly]

Recruiting NA
Feb 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Armed Forces Research Institute of Medical Sciences, Thailand
University of North Carolina, Chapel Hill

Data source: Armed Forces Research Institute of Medical Sciences, Thailand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Khun Han, Thailand